International Hyaluronate Injection (Sodium Hyaluronate)
Sodium Hyaluronate 15mg
Prescription medication
International Pharmaceutical Co., Ltd.
MFDS item code 201101134 · Notified 2011.03.07 · Insurance code 643703371
Adjunctive treatment in ophthalmic surgery (such as cataract surgery and corneal transplantation)
This drug is used as an adjunct in various ophthalmic surgeries, including aiding in intraocular lens implantation during cataract surgery, corneal transplantation, and glaucoma surgeries. It helps facilitate recovery after surgery and increases the success rate of the procedures. It is effective as an adjunct for those undergoing ophthalmic surgeries.
1. Cataract surgery and intraocular lens implantation Slowly inject the required amount of this drug into the anterior chamber of the eye through a needle or cannula, before or after lens removal. To optimize its corneal endothelial protective effect as an adjunct, it should be injected before cataract extraction or intraocular lens implantation; therefore, inject it before intracapsular or extracapsular cataract surgery. This drug may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation After removing the corneal graft, fill the anterior chamber with this drug until its level is even with the corneal surface. Place the donor graft on top of this drug and suture it in place. 3. Glaucoma filtration surgery Inject this drug through a corneal paracentesis to replenish and maintain the volume of the anterior chamber during trabeculectomy.
This drug should not be used in patients who have had allergic reactions to the ingredients or drugs in the protein family. Eye-related side effects may occasionally include increased intraocular pressure or, rarely, inflammation inside the eye. Additionally, corneal edema, opacification, bleeding, new blood vessel growth in the iris, or ulceration may occur. Symptoms such as eye pain, itching, and blurred vision may also appear, so caution is advised. After using this drug, opacification may occur on the surface of the intraocular lens, and phosphates in the additive have been reported to cause rare occurrences of calcification of the cornea in patients with severe corneal damage. Particularly immediately after surgery, careful monitoring of intraocular pressure is essential, and appropriate treatment should be administered if pressure increases. After surgery, it is advisable to cleanse or aspirate this drug as much as possible. Before performing ultrasonic emulsification and aspiration, a space filled with perfusion fluid must be created between the lens and this drug through aspiration perfusion. Surgical instruments should not be cleaned with solutions containing quaternary ammonium compounds such as benzalkonium chloride, and there may be contraindicated medications when used with this drug, so consulting a medical professional is necessary. This drug is intended for ophthalmic use only and must never be injected intravascularly. Before use, it should be kept refrigerated and allowed to reach room temperature for about 30 minutes. After opening, it should only be used once, and any remaining drug should be discarded. During injection, care should be taken to avoid air entering beneath the iris, and injection should be performed slowly and carefully, as excessive injection may lead to an increase in intraocular pressure.
Increased intraocular pressure, inflammatory response, corneal edema, corneal opacity, anterior bleeding, iris neovascularization, posterior iris ulcer, conjunctival adhesions, mydriasis, lens opacification, pain, pruritus, blurred vision, corneal dysfunction, opacification of the anterior surface of the intraocular lens, corneal calcification
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to protect it from air and light exposure. It is important to avoid direct sunlight and store it in a cool place. The storage temperature should be maintained between 2 degrees and 8 degrees Celsius, and care should be taken to prevent the drug from freezing.
A colorless, viscous liquid contained in a glass vial or plastic tube sealed with rubber stoppers (part of a prefilled syringe system).
0.85 milliliters/piece
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Hyaluronate 15mg
Prescription medication
International Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Dongkuk Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Youyoung Pharmaceutical Co., Ltd.
Sodium Hyaluronate 1mg
Eye drops · Prescription medication
Samil Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Injections · Prescription medication
Alcon Korea Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Donggwang Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Iyeon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.